Published in J Exp Med on October 01, 1964
The role of the alkaline earth ions in anaphylactic histamine secretion. J Physiol (1972) 4.03
House-dust mite asthma. Results of challenge tests on five criteria with Dermatophagoides pteronyssinus. Br Med J (1970) 2.56
Studies of allograft immunity in mice. II. Mechanism of target cell inactivation in vitro by sensitized lymphocytes. Immunology (1970) 2.49
Allergic asthma in childhood. Arch Dis Child (1969) 2.45
Histamine release from human leukocytes: studies with deuterium oxide, colchicine, and cytochalasin B. J Clin Invest (1972) 1.98
Effects of cholera toxin on in vitro models of immediate and delayed hypersensitivity. Further evidence for the role of cyclic adenosine 3',5'-monophosphate. J Clin Invest (1973) 1.94
The effect of phospholipids on anaphylactic histamine release. Br J Pharmacol (1972) 1.81
Immunologic and cellular changes accompanying the therapy of pollen allergy. J Clin Invest (1971) 1.80
Generation of leukotrienes by purified human lung mast cells. J Clin Invest (1982) 1.77
Desensitization in the process of histamine secretion induced by antigen and dextran. J Physiol (1974) 1.74
IgE receptors on human basophils. Relationship to serum IgE concentration. J Clin Invest (1978) 1.71
Detection of allergy to penicillin and other antigens by in-vitro passive sensitization and histamine release from human and monkey lung. Br Med J (1968) 1.70
Activation of basophil and mast cell histamine release by eosinophil granule major basic protein. J Exp Med (1983) 1.69
IgE and IgGa antibody-mediated release of histamine from rat peritoneal cells. I. Optimum conditions for in vitro preparation of target cells with antibody and and challenge with antigen. J Exp Med (1971) 1.64
Antagonism by beta-adrenoceptor blocking agents of the antianaphylactic effect of isoprenaline. Br J Pharmacol (1971) 1.61
Release of cartilage mucopolysaccharide-degrading neutral protease from human leukocytes. J Exp Med (1973) 1.60
IgE antibody measurements in ragweed hay fever. Relationship to clinical severity and the results of immunotherapy. J Clin Invest (1973) 1.58
Serum reagins and leucocyte response in patients with house-dust mite allergy. Br Med J (1970) 1.52
Interleukin 3-dependent mediator release in basophils triggered by C5a. J Exp Med (1989) 1.48
Surface IgE on human basophils during histamine release. J Exp Med (1973) 1.48
Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. J Clin Invest (1985) 1.45
The ability of thapsigargin and thapsigargicin to activate cells involved in the inflammatory response. Br J Pharmacol (1985) 1.40
Specific leukocyte receptors for small endogenous hormones. Detection by cell binding to insolubilized hormone preparations. J Clin Invest (1973) 1.39
The mechanism of anaphylactic histamine release from rabbit leucocytes. Immunology (1968) 1.36
Expression of CD203c and CD63 in human basophils: relationship to differential regulation of piecemeal and anaphylactic degranulation processes. Clin Exp Allergy (2010) 1.35
A pH-stabilizing role of voltage-gated proton channels in IgE-mediated activation of human basophils. Proc Natl Acad Sci U S A (2008) 1.30
Adenosine inhibits and potentiates IgE-dependent histamine release from human basophils by an A2-receptor mediated mechanism. Br J Pharmacol (1983) 1.29
In vitro studies of human ragweed allergy: changes in cellular and humoral activity associated with specific desensitization. J Clin Invest (1966) 1.29
In vitro reversed anaphylaxis: characteristics of anti-IgE mediated histamine release. Immunology (1970) 1.24
IgE-mediated hypersensitivity in human skin studied using a new in vitro method. Immunology (1972) 1.24
Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines. J Clin Invest (1997) 1.22
IgE and IgGa antibody-mediated release of histamine from rat peritoneal cells. II. Interaction of IgGa and IgE at the targe cell. J Exp Med (1971) 1.21
Hyperosmolar triggering of histamine release from human basophils. J Clin Invest (1981) 1.21
Cell-mediated immune response of ragweed-sensitive patients to ragweed antigen E. In vitro lymphocyte transformation and elaboration of lymphocyte mediators. J Clin Invest (1974) 1.21
Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release. J Clin Invest (1979) 1.20
Anaphylactic release of a basophil kallikrein-like activity. I. Purification and characterization. J Clin Invest (1979) 1.20
Regulation of Ca2+ signaling with particular focus on mast cells. Crit Rev Immunol (2009) 1.20
Characterization of human platelet vascular permeability-enhancing activity. J Clin Invest (1972) 1.20
Mediators of histamine release from human platelets, lymphocytes, and granulocytes. J Clin Invest (1971) 1.19
Anti-immunoglobulin-induced histamine secretion by rat peritoneal mast cells studied by immunoferritin electron microscopy. J Exp Med (1975) 1.18
IgA and IgG anti-ragweed antibodies in nasal secretions. Quantitative measurements of antibodies and correlation with inhibition of histamine release. J Clin Invest (1976) 1.17
Electron microscopic localization of immunoglobulin E on the surface membrane of human basophils. J Exp Med (1971) 1.15
Studies on "allergoids" prepared from naturally occurring allergens. I. Assay of allergenicity and antigenicity of formalinized rye group I component. Immunology (1970) 1.11
The histamine content of rabbit leucocytes and its release during in vitro anaphylaxis. Immunology (1968) 1.08
In vitro adhesion of eosinophils to infective larvae of Wuchereria bancrofti. Immunology (1970) 1.06
Canine reaginic antibody. Characterization of the spontaneous anti-ragweed and induced anti-dinitrophenyl reaginic antibodies of the atopic dog. Clin Exp Immunol (1971) 1.04
Complement-dependent histaminase release from human granulocytes. J Clin Invest (1979) 1.04
The antigen-induced degranulation of basophil leucocytes from atopic subjects, studied by phase-contrast microscopy. Clin Exp Immunol (1971) 1.02
Antigen-indued histamine release from peritoneal mast cells of mice producing reagin-like antibody. Immunology (1968) 1.01
Mechanisms underlying allergy vaccination with recombinant hypoallergenic allergen derivatives. Vaccine (2011) 1.01
Effects of cyclic AMP- and cyclic GMP- phosphodiesterase inhibitors on immunological release of histamine and on lung contraction. Br J Pharmacol (1981) 1.00
Histaminase release from human granulocytes. J Exp Med (1976) 1.00
Tests for penicillin allergy in man. II. The immunological cross-reaction between penicillins and cephalosporins. Immunology (1974) 0.98
Investigative studies of the dermatitis caused by the larva of the brown-tail moth, Euproctis chrysorrhoea l. (Lepidoptera, Lymantriidae). IV. Further characterization of skin reactive substances. Arch Dermatol Res (1977) 0.97
Histamine release from platelets for assay of byssinogenic substances in cotton mill dust and related materials. Br J Ind Med (1979) 0.97
Desensitization of the neutrophil aggregation response to chemotactic factors. Am J Pathol (1978) 0.97
Anaphylactic hyposensitization of rat mast cells in vitro by antigen. Clin Exp Immunol (1974) 0.96
Anaphylactic relase of a basophil kallikrein-like activity. II. A mediator of immediate hypersensitivity reactions. J Clin Invest (1979) 0.96
Histamine release in the dog after leukocyte lysate injection. Infect Immun (1971) 0.96
Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release. J Clin Invest (1988) 0.95
Immunological responses to L-asparaginase. J Clin Invest (1971) 0.94
Induction of IgE-mediated immediate hypersensitivity to group I rye grass pollen allergen and allergoids in non-allergic man. Immunology (1972) 0.94
Immunological investigation of individuals with toluene diisocyanate asthma. Clin Exp Immunol (1969) 0.94
In vitro detection of human reagins by double layer leucocyte agglutination: method and controlled blind study. Immunology (1967) 0.94
Liver damage and isoniazid allergy. Clin Exp Immunol (1969) 0.93
Defective histamine release in chronic urticaria. J Clin Invest (1976) 0.93
A linear correlation between histamine release and degranulation of human basophils by specific antigen or the ionophore A23187. Immunology (1980) 0.92
Endogenous histamine excites neurones in the guinea-pig superior cervical ganglion in vitro. J Physiol (1989) 0.91
Identification of the endings and function of cat fusimotor fibres. J Physiol (1971) 0.90
Tests for penicillin allergy in man. I. Carrier effect on response to penicilloyl conjugates. Immunology (1974) 0.90
Concanavalin A induced histamine release from human basophils in vitro. Immunology (1977) 0.90
Activation of human basophils by staphylococcal protein A. I. The role of cyclic AMP, arachidonic acid metabolites, microtubules and microfilaments. Clin Exp Immunol (1982) 0.88
A species comparison of the histamine H2-receptor on mast cells and basophils. Agents Actions (1982) 0.88
Spontaneous histamine secretion from mast cells in the presence of strontium. J Physiol (1977) 0.88
Release of histamine from hamster mast cells by concanavalin A and phytohemagglutinin. Infect Immun (1974) 0.87
Histamine release induced by human leukocyte lysates. Reabsorption of previously released histamine after exposure to cyclic amp-active agents. J Clin Invest (1973) 0.86
IgE epitope proximity determines immune complex shape and effector cell activation capacity. J Allergy Clin Immunol (2015) 0.85
Histamine release induced by himan leukocyte lysates: implication of a specific, complement-independent, noncytotoxic reaction. Infect Immun (1973) 0.84
Histamine release from human leukocytes when stimulated by Mycoplasma salivarium. Infect Immun (1975) 0.84
Effect of sympathomimetic amines on the histamine forming capacity of human leucocytes. Br J Pharmacol (1974) 0.83
Histamine release from human leukocytes: modulation by a cytochalasin B-sensitive barrier. J Clin Invest (1972) 0.83
Influence of anions, cations and osmolarity on IgE-mediated histamine release from human basophils. Immunology (1981) 0.82
Inhibition of human cutaneous anaphylaxis by cytochalasin B. Immunology (1973) 0.81
Effects of silybin on histamine release from human basophil leucocytes. Br J Clin Pharmacol (1987) 0.80
Histamine release induced by human leukocyte lysates: effect of metabolic inhibitors and carbohydrates. Infect Immun (1973) 0.79
IgE rheumatoid factors: quantification in synovial fluid and ability to induce synovial mast cell histamine release. Clin Exp Immunol (1988) 0.78
Nasal secretory antibody to inhalant allergens in allergic and non-allergic patients. Immunology (1970) 0.77
Histamine release from human leucocytes. A serum factor necessary for the induction of histamine release and desensitization by protein A. Immunology (1977) 0.77
Granulocyte-macrophage colony-stimulating factor and interleukin-3 cause basophil histamine release by a common pathway: downregulation by sodium. Immunology (1999) 0.76
Anti-IgE autoantibodies in systemic sclerosis (scleroderma). Ann Rheum Dis (1989) 0.75
Treatment of anaphylactic shock. Br Med J (1971) 0.75
Influence of preseasonal treatment with L-tyrosine-adsorbed allergoids on IgE-mediated histamine release from basophils of children suffering from allergic diseases. Agents Actions (1981) 0.75
Allergy: immunity gone wrong. Proc R Soc Med (1973) 0.75
Inhibition of the release of mediators of immediate-type allergy in vivo and in vitro. Proc R Soc Med (1973) 0.75
Advances in asthma. Treatment. Br Med J (1969) 0.75
Low MW B-cell growth factor potentiates histamine release from human basophil leucocytes. Immunology (1991) 0.75
Immunological release of histamine and slow-reacting substance in domestic fowl. Can J Comp Med (1978) 0.75
Studies of HLA antigen frequencies, IgE levels, and specific allergic sensitivities in patients having ragweed hayfever, with and without asthma. Clin Exp Immunol (1976) 0.75
Human reagins: appraisal of the properties of the antibody of immediate-type hypersensitivity. Bacteriol Rev (1972) 0.75
High IgE concentration in a patient with a chronic stomach ulcer. Can Med Assoc J (1977) 0.75
A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther (1959) 16.61
Determination of cell viability. Proc Soc Exp Biol Med (1958) 5.86
Studies on the mechanism of hypersensitivity phenomena. III. The participation of complement in the formation of anaphylatoxin. J Exp Med (1959) 3.83
Cellular mechanisms in anaphylaxis. Physiol Rev (1962) 2.87
Distribution of histamine among leukocytes and platelets. Blood (1955) 2.29
Gamma globulin and molecular mechanisms in hypersensitivity reactions. Prog Allergy (1963) 2.10
The release of histamine from rabbit platelets by means of antigen-antibody precipitates. I. The participation of the immune complex in histamine release. J Immunol (1961) 1.98
ISOLATION AND CHARACTERIZATION OF ALLERGENS FROM RAGWEED POLLEN. II. Biochemistry (1964) 1.97
A quantitative study on the in vitro release of histamine from leukocytes of atopic persons. J Allergy (1958) 1.48
Correlation of blood histamine release and skin test response to multiple antigens. J Allergy (1955) 1.37
Release of histamine in the blood of ragweed-sensitive individuals. J Allergy (1954) 1.31
The effect of excess antigen on the anaphylactic reaction. J Immunol (1963) 1.31
An improved method for isolating viable human leukocytes from peripheral blood. Blood (1958) 1.24
The effect of hyposensitization on the in vitro histamine release by specific antigen. J Allergy (1961) 1.23
Kinetic studies on immune hemolysis. III. Description of a terminal process which follows the Ca++ and Mg++ reaction steps in the action of complement on sensitized erythrocytes. J Immunol (1954) 1.14
Diagnostic complement fixation. I. A method. Am J Syph Gonorrhea Vener Dis (1952) 7.02
Studies on the mechanism of hypersensitivity phenomena. III. The participation of complement in the formation of anaphylatoxin. J Exp Med (1959) 3.83
Studies on the mechanism of hypersensitivity phenomena. II. The participation of complement in passive cutaneous anaphylaxis of the albino rat. J Exp Med (1957) 3.31
Quantitative studies of complement fixation. V. Estimation of complement-fixing potency of immune sera and its relation to antibody-nitrogen content. J Immunol (1950) 2.82
Studies on the role of Ca++ and Mg++ in complement fixation and immune hemolysis. I. Uptake of complement nitrogen by specific precipitates and its inhibition by ethylenediamine tetraacetate. J Immunol (1953) 2.07
Quantitative studies of complement fixation. Bacteriol Rev (1958) 2.06
IN VITRO DAMAGE OF RABBIT PLATELETS BY AN UNRELATED ANTIGEN-ANTIBODY REACTION. I. GENERAL CHARACTERISTICS OF THE REACTION. J Immunol (1965) 1.75
Studies on the role of Ca++ and Mg++ in complement fixation and immune hemolysis. II. The essential role of calcium in complement fixation. J Immunol (1953) 1.68
Studies on the inhibition of immune hemolysis by phlorizin. J Immunol (1960) 1.54
Studies on the role of Ca++ and Mg++ in complement fixation and immune hemolysis. III. The respective roles of Ca++ and Mg++ in immune hemolysis. J Immunol (1953) 1.51
Kinetic studies of complement fixation. II. The role of the aggregating capacity of antibody and its heterogeneity. J Immunol (1955) 1.46
Immunologic studies of systemic lupus erythematosus. II. Variations of nucleoprotein-reactive gamma globulin and hemolytic serum complement levels with disease activity. Bull Johns Hopkins Hosp (1963) 1.06
Chromatographic purification and serologic studies of a beef heart lecithin. J Biol Chem (1951) 0.96
Quantitative studies of lipid-soluble tissue antigens as exemplified by the Wassermann antigen-antibody system. II. Comparative studies with mammalian and plant tissue phospholipids. J Immunol (1957) 0.95
Kinetic studies of complement fixation. I. A method. J Immunol (1955) 0.92
The fixation of complement by human sera and alcoholic extracts of human cardiac tissue. Am J Syph Gonorrhea Vener Dis (1954) 0.90
Studies on the mechanism of hypersensitivity phenomena. I. The effect of in vivo antigen-antibody reactions on passive cutaneous anaphylaxis in the rat. Int Arch Allergy Appl Immunol (1955) 0.90
Studies on the mechanism of hypersensitivity phenomena. IV. An isometric smooth muscle assay system. Immunology (1961) 0.87
INTERACTION OF RHEUMATOID FACTORS WITH AGGREGATED SUBUNITS OF HUMAN GAMMA-GLOBULIN. J Immunol (1965) 0.87
Effect of fetal or neonatal immunization on antibody response of the adult rat. Proc Soc Exp Biol Med (1957) 0.82
IMMUNOLOGIC ASPECTS OF HUMAN REAGINIC ALLERGY: AN IN VITRO METHOD AND SOME APPLICATIONS. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1965) 0.80
HISTAMINE RELEASE FROM RABBIT PLATELETS. Methods Med Res (1964) 0.80
Immunologic studies of systemic lupus erythematosus. I. Quantitative estimations of nucleoprotein-reactive gamma globulin in systemic lupus erythematosis and other diseases. Bull Johns Hopkins Hosp (1963) 0.78
Diagnostic complement fixation. II. Application to the serodiagnosis of syphilis. Am J Syph Gonorrhea Vener Dis (1952) 0.76
Immunologic studies of autochthonous cancer: an evaluation of several procedures. Cancer Res (1961) 0.76
Studies on the mechanism of hypersensitivity phenomena. V. Antigen-antibody interaction in the guinea-pig small intestine. Immunology (1961) 0.75
Anaphylatoxin, passive cutaneous anaphylaxis and complement-their possible relation to clinical allergy. N Y State J Med (1960) 0.75
[Experimental research on the passage of antigen and antibody into the intraocular fluids]. Boll Ocul (1961) 0.75
Studies in enterococcal food poisoning; the isolation of enterococci from foods implicated in several outbreaks of poisoning. Public Health Rep (1948) 0.75
Quantitative studies of complement fixation; fixation of complement in the reaction between type III pneumococcus specific polysaccharide and homologous antibody. J Immunol (1948) 0.75
Quantitative studies of complement fixation. Proc Soc Exp Biol Med (1947) 0.75
Experimental enterococcal food poisoning in man. Proc Soc Exp Biol Med (1948) 0.75
A rapid slide method for the titration of antibodies in syphilitic serum. J Vener Dis Inf (1948) 0.75
MAST CELL DEGRANULATION. Methods Med Res (1964) 0.75
QUANTITATIVE MEASUREMENT OF NUCLEOPROTEIN-REACTIVE GAMMA GLOBULINS IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RELATED DISEASES. Methods Med Res (1964) 0.75
Quantitative studies of lipid-soluble tissue antigens as exemplified by the Wassermann antigen-antibody system. I. Estimation of the Wassermann antibody in absolute weight units. J Immunol (1957) 0.75
ANTIGEN-ANTIBODY INTERACTION IN GUINEA PIG SMALL INTESTINE (SCHULTS-DALE REACTION). Methods Med Res (1964) 0.75
Quantitative studies of complement-fixation; homologous and cross-reactions in pneumococcal type III and type VIII systems. J Immunol (1948) 0.75
Quantitative studies of complement-fixation; homologous and cross-reactions in chicken- and duck-egg-albumin systems. J Immunol (1948) 0.75
Quantitative studies of complement fixation; a method. J Immunol (1948) 0.75